Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
Figure 1
Drug combination settings used in this study. PC3 and DU145 cells were exposed to and at various concentrations and mixing ratios for 72 hours. Dots on the lines denoted as Combination 1, 2, 3, and 4 indicate data points used to determine the combination index and cytotoxicity values.
